Insulin access and affordability in the USA: anticipating the first interchangeable insulin product

Lancet Diabetes Endocrinol. 2020 May;8(5):360-362. doi: 10.1016/S2213-8587(20)30105-4. Epub 2020 Mar 20.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biosimilar Pharmaceuticals / therapeutic use
  • Costs and Cost Analysis
  • Drug Costs*
  • Drugs, Generic / therapeutic use
  • Health Services Accessibility*
  • Humans
  • Insulin / economics*
  • Insulin / therapeutic use
  • United States

Substances

  • Biosimilar Pharmaceuticals
  • Drugs, Generic
  • Insulin